(2R,4R)-4-(tert-butoxy)-1-[(9H-fluoren-9- ylmethoxy)carbonyl]pyrrolidine-2- carboxylic
| Product Name | (2R,4R)-4-(tert-butoxy)-1-[(9H-fluoren-9- ylmethoxy)carbonyl]pyrrolidine-2- carboxylic |
|---|---|
| Alternate Names | - Impurities, Impurities of - |
| CAT No. | CS-BX-02695 |
| CAS No. | 1276694-30-4 |
| Category | Impurities |
| Stock | Enquire |
| Mol. Wt. | 409.47 g/mol |
| Mol. For. | C24H27NO5 |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | - |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
![Picture of (2R,4R)-4-(tert-butoxy)-1-[(9H-fluoren-9- ylmethoxy)carbonyl]pyrrolidine-2- carboxylic](https://clearsynth.com/structure/-2R-4R--4--tert-butoxy--1---9H-fluoren-9--ylmethoxy-carbonyl-pyrrolidine-2--carboxylic.png)
Get an Instant Quote
Related Compounds
Ethyl 6-bromo-4-[(dimethylamino)methyl]-5-hydroxy-1,2-dimethyl-1H-indole-3-carboxylate | Chloromethylisothiazolinone-methylisothiazolinone Mixture | Nintedanib Impurity 63 | Fmoc-L-His(2-Oxo)-OH | Resmetirom Impurity 3 | N-methyl-N-(4-nitrosophenyl)nitrous amide | Fmoc-Val-Ser[Psi(Me,Me)Pro]-OH | N-ethyl-N-isopropyl ethylenediamine | Resmetirom Impurity 9 | Nandrolone cypionate | Ceftriaxone 3-ene Isomer Disodium Salt | Methyl 2-bromo-2-(4-chlorophenyl)acetate | Hydrocortisone Impurity - 18 | propane-1,2,3-triyl triethane sulfonate | Safinamide ring closed impurity | methyl 2,4-dichloro-3-oxopentanoate | Piperacillin Impurity I | N-Methyl-N-nitrosourethane | Sofosbuvir impurity A | Atorvastatin Impurity D ( Mixture of compounds ) | Nandrolone furylpropionate | Nonylphenol | Larotrectinib Urea dimer impurity | Fmoc-Gly-OH-1-13C | Triiodothyroacetic acid sulfate | Zanubrutinib Mesyl impurity | Larotrectinib hydrogen sulfate Impurity | TBDMS 1α,25-dihydroxyvitamin D2 aldehyde impurity | Carbomer Interpolymer type A | N,S-(Dicarboxymethyl)cysteine | Oxo(OtBu)-γ-Glu(α-OtBu)-AEEA-OH | Benzene,1,2-Dichloro-3-(dibromomethyl) | Estradiol impurities - 1 | Sodium (R)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxylate | N-Nitroso Silodosin Nitrile Impurity | Neopetasin | Lumefantrine Hydroxy impurity (Mixture of Isomers) | DGK-IN-1 | D-Cysteine Methyl Ester | N-Nitroso-N-methylcyclohexylamine 1mg/ml in MeOH | Bis-anhydro-Daunomycinone Carboxylic Acid | Cephalosporanic acid G | Sacubitril Impurity 14 | N,N-Diethylglycine 2-[2-[(5-chloro-2-nitrophenyl)thio]phenyl]hydrazide | Potassium 2-(4-chlorobenzamido)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoate | Zanubrutinib Dimer impurity | Ethyl (R)-3-(3-(2,4-dihydroxy-3,3-dimethylbutanamido)propanamido)propanoate | Polybutylene terephthalate Impurity 2 | Quetiapine EP Impurity P diHCl salt | Heptacarboxylporphyrin I Dihydrochloride | Methyl 3-(4-methoxyphenyl)-2-methyloxirane-2-carboxylate | Triethyl 1,3,5-benzenetricarboxylate | Benzyl (3R,4S)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate | Tandospirone Citrate Impurity I | Dydrogesterone Impurity C | Ciclosporin impurity (NAP 005-95) | N-Formyl Nebivolol | Diethyl ethoxyoxalacetate | cisplatin dihydrate impurity | Methyl 4-[(2R,4S)-4-ethoxy-2-piperidinyl]benzoate | Ethyl N-[2-cyano-2-[2-[3,5-dichloro-4-[[1,6-dihydro-5-(1-methylethyl)-6-oxo-3-pyridazinyl]oxy]phenyl]hydrazinylidene]acetyl]carbamate | Fmoc-O-tert-butyl-D-trans-4-hydroxyproline | Larotrectinib (3R,2R) Sulfate | Methyl 4-chloro-3-oxopentanoate | Ethylene Terephthalate Cyclic Pentamer-d20 | Prenderol | Resmetirom Impurity 2 | Ouratea proanthocyanidin A | Lubiprostone Related Compound 7 | N-((1S)-1-carboxy-2-methyl propyl)-N,N-bis[(2'-cyanobiphenyl-4-yl)methyl]-1-oxopentan-1-aminium chloride |
